Earlier PCSK9 drugs faced years of payer skepticism until CV outcomes trials proved they cut heart attacks/strokes, not just LDL
Multiple lines of evidence indicate that L-carnitine supplementation modulates these regulatory networks in NAFLD/NASH models
Heart rate checks: ask patients to record resting pulse or use clinic vitals
doi: 10.3389/fcvm.2025.1731127 Received 23 October 2025 Revised 15 November 2025 Accepted 28 November 2025 Published 15 December 2025 Volume 12 - 2025 Edited by Manfredi Tesauro, University of Rome Tor Vergata, Italy Reviewed by Angelo Maria Patti, University of Palermo, Italy Antonio Maria Labate, ASST Franciacorta, Italy Updates Copyright 2025 Tan, Yin and Lu
Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: a randomized, placebo-controlled, double-blind, parallel-group study
BPC-157 (as PL-14736) was evaluated in early human inflammatory-bowel-disease/ulcerative-colitis trials and reportedly in multiple-sclerosis trials